SCHEMBL4350869

SCHEMBL4350869

CN1CCC(Oc2cccc(CCOc3cc(-n4cnc5cc(-c6ccc(F)nc6)ccc54)sc3C(=O)O)c2Cl)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 19/20 0.46
CYP3A4 P08684 8/20 0.46
CYP2C9 P11712 4/20 0.46
NEK2 P51955 7/20 0.44
PLK3 Q9H4B4 6/20 0.41
PIM1 P11309 3/20 0.41
KDR P35968 3/20 0.41
PIK3CD O00329 2/20 0.41
NUAK1 O60285 2/20 0.41
PDGFRB P09619 2/20 0.41
PLK4 O00444 1/20 0.39
CHEK1 O14757 1/20 0.39
AURKA O14965 1/20 0.39
DAPK3 O43293 1/20 0.39
JAK2 O60674 1/20 0.39
CHEK2 O96017 1/20 0.39
INSR P06213 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
CDK1 P06493 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3604366 0.86 PLK1 (0.59) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL13440250 0.80 PLK1 (0.67) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL3259410 0.80 PLK1 (0.67) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL4553114 0.80 PLK1 (0.60) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL3255762 0.80 PLK1 (0.60) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL3615205 0.77 PLK1 (0.58) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL3612499 0.74 PLK1 (0.56) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL13440213 0.73 PLK1 (0.68) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL3250936 0.73 PLK1 (0.68) PLK1CYP3A4CYP2C9NEK2PLK3
SCHEMBL3609564 0.73 PLK1 (0.57) PLK1CYP3A4CYP2C9NEK2PLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615643-B2 3-[((1R)-1-{2-Chloro-3-[(1-methyl-4-piperidinyl)oxy]phenyl}ethyl)oxy]-5-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]-2-thiophenecarboxamide; polo like kinase enzyme inhibitors; anticarcinogenic agents for treating cancer SMITHKLINE BEECHAM CORPORATION (US) 2009-11-10 US disclosed